Furthermore, the Overall survival (OS) of patients with HCC with a low serum ApoA-1 level was significantly shorter (p=0.027, Figure 1B) compared with those with a high ApoA-1 level (34.15% vs. 21.83%). The gene discussed is APOA1; the disease is hepatocellular carcinoma.